Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225589081> ?p ?o ?g. }
- W4225589081 abstract "Abstract Body weight loss of ≥ 10% improves the metabolic derangements and liver disease in the majority of non-alcoholic steatohepatitis (NASH) patients, suggesting metabolic modulators may be effective in controlling disease. The pharmacodynamics of ALT-801, a GLP-1/glucagon receptor dual agonist optimized for NASH and weight loss, were compared to semaglutide (GLP-1 receptor agonist) and elafibranor (peroxisome proliferator-activated receptor, PPAR-α/δ, agonist) in a biopsy-confirmed, diet-induced obese (DIO) mouse model of NASH (DIO-NASH). Male C57BL/6J mice were fed Amylin Liver NASH (AMLN) diet for 32 weeks. Animals with biopsy-confirmed steatosis and fibrosis received ALT-801, semaglutide, elafibranor, or vehicle daily for 12 weeks while maintained on the AMLN diet. Study endpoints included body and liver weight, liver and plasma total cholesterol and triglycerides, plasma aminotransferases, histological analysis of liver steatosis, inflammation (galectin-3) and fibrosis (collagen type 1 alpha 1), and evaluation of individual animal changes in composite Non-alcoholic Fatty Liver Disease Activity Score (NAS), and fibrosis stage. ALT-801 demonstrated significant reductions in body weight (approx. 25%), plasma aminotransferases, plasma total cholesterol and liver triglycerides/total cholesterol in conjunction with improved liver steatosis, with greater reductions ( p < 0.05) compared to semaglutide and elafibranor. ALT-801 significantly reduced the inflammation marker galectin-3 and the fibrosis marker collagen type 1 alpha 1 vs. vehicle ( p < 0.05), with ALT-801 producing greater reductions in galectin-3 vs. elafibranor ( p < 0.05). Importantly, all animals treated with ALT-801 significantly improved composite NAS compared to the active controls. This study provides evidence for a potential role for ALT-801 in the therapeutic treatment of NASH." @default.
- W4225589081 created "2022-05-05" @default.
- W4225589081 creator A5039020547 @default.
- W4225589081 creator A5049562432 @default.
- W4225589081 creator A5067265775 @default.
- W4225589081 creator A5070162381 @default.
- W4225589081 creator A5077809872 @default.
- W4225589081 date "2022-04-23" @default.
- W4225589081 modified "2023-10-10" @default.
- W4225589081 title "Effects of ALT-801, a GLP-1 and glucagon receptor dual agonist, in a translational mouse model of non-alcoholic steatohepatitis" @default.
- W4225589081 cites W1979288606 @default.
- W4225589081 cites W1997425045 @default.
- W4225589081 cites W2014718725 @default.
- W4225589081 cites W2059222532 @default.
- W4225589081 cites W2066841620 @default.
- W4225589081 cites W2067740038 @default.
- W4225589081 cites W2081943624 @default.
- W4225589081 cites W2091106363 @default.
- W4225589081 cites W2092700213 @default.
- W4225589081 cites W2093182588 @default.
- W4225589081 cites W2122188063 @default.
- W4225589081 cites W2123578975 @default.
- W4225589081 cites W2132295069 @default.
- W4225589081 cites W2162140339 @default.
- W4225589081 cites W2169848635 @default.
- W4225589081 cites W2253420963 @default.
- W4225589081 cites W2264277632 @default.
- W4225589081 cites W2289794410 @default.
- W4225589081 cites W2464238397 @default.
- W4225589081 cites W2469365710 @default.
- W4225589081 cites W2730267177 @default.
- W4225589081 cites W2737010114 @default.
- W4225589081 cites W2751736739 @default.
- W4225589081 cites W2766120686 @default.
- W4225589081 cites W2772777089 @default.
- W4225589081 cites W2783806692 @default.
- W4225589081 cites W2784607695 @default.
- W4225589081 cites W2790574529 @default.
- W4225589081 cites W2810819338 @default.
- W4225589081 cites W2886911834 @default.
- W4225589081 cites W2902635267 @default.
- W4225589081 cites W2924479779 @default.
- W4225589081 cites W2954905478 @default.
- W4225589081 cites W2971782246 @default.
- W4225589081 cites W2979558564 @default.
- W4225589081 cites W2982276250 @default.
- W4225589081 cites W3004644667 @default.
- W4225589081 cites W3034346518 @default.
- W4225589081 cites W3125707497 @default.
- W4225589081 cites W3127371223 @default.
- W4225589081 cites W3136380725 @default.
- W4225589081 cites W3177122952 @default.
- W4225589081 cites W3202116011 @default.
- W4225589081 doi "https://doi.org/10.1038/s41598-022-10577-2" @default.
- W4225589081 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35461369" @default.
- W4225589081 hasPublicationYear "2022" @default.
- W4225589081 type Work @default.
- W4225589081 citedByCount "11" @default.
- W4225589081 countsByYear W42255890812022 @default.
- W4225589081 countsByYear W42255890812023 @default.
- W4225589081 crossrefType "journal-article" @default.
- W4225589081 hasAuthorship W4225589081A5039020547 @default.
- W4225589081 hasAuthorship W4225589081A5049562432 @default.
- W4225589081 hasAuthorship W4225589081A5067265775 @default.
- W4225589081 hasAuthorship W4225589081A5070162381 @default.
- W4225589081 hasAuthorship W4225589081A5077809872 @default.
- W4225589081 hasBestOaLocation W42255890811 @default.
- W4225589081 hasConcept C126322002 @default.
- W4225589081 hasConcept C134018914 @default.
- W4225589081 hasConcept C170493617 @default.
- W4225589081 hasConcept C2775934546 @default.
- W4225589081 hasConcept C2776175330 @default.
- W4225589081 hasConcept C2777180221 @default.
- W4225589081 hasConcept C2777766500 @default.
- W4225589081 hasConcept C2778772119 @default.
- W4225589081 hasConcept C2778938600 @default.
- W4225589081 hasConcept C2779134260 @default.
- W4225589081 hasConcept C2779478299 @default.
- W4225589081 hasConcept C2780559512 @default.
- W4225589081 hasConcept C2781308992 @default.
- W4225589081 hasConcept C555293320 @default.
- W4225589081 hasConcept C71924100 @default.
- W4225589081 hasConceptScore W4225589081C126322002 @default.
- W4225589081 hasConceptScore W4225589081C134018914 @default.
- W4225589081 hasConceptScore W4225589081C170493617 @default.
- W4225589081 hasConceptScore W4225589081C2775934546 @default.
- W4225589081 hasConceptScore W4225589081C2776175330 @default.
- W4225589081 hasConceptScore W4225589081C2777180221 @default.
- W4225589081 hasConceptScore W4225589081C2777766500 @default.
- W4225589081 hasConceptScore W4225589081C2778772119 @default.
- W4225589081 hasConceptScore W4225589081C2778938600 @default.
- W4225589081 hasConceptScore W4225589081C2779134260 @default.
- W4225589081 hasConceptScore W4225589081C2779478299 @default.
- W4225589081 hasConceptScore W4225589081C2780559512 @default.
- W4225589081 hasConceptScore W4225589081C2781308992 @default.
- W4225589081 hasConceptScore W4225589081C555293320 @default.
- W4225589081 hasConceptScore W4225589081C71924100 @default.
- W4225589081 hasIssue "1" @default.
- W4225589081 hasLocation W42255890811 @default.
- W4225589081 hasLocation W42255890812 @default.